Kreutzman, Anna <br/><br/>
Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia.  [electronic resource] 

 -  Experimental hematology  Nov 2012 
 - 906-913.e1 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2399 
<br/><br/><label>Standard No.: </label>10.1016/j.exphem.2012.07.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Dasatinib<br/>Gene Expression Profiling<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Pyrimidines--therapeutic use<br/>Receptors, KIR--genetics<br/>Thiazoles--therapeutic use